Zoledronate, fractures, and mortality after hip fracture.
Lopez
Cesar A
CA
Tasneem
Zahra
Z
D001281:Atrial Fibrillation / Q000139:chemically induced; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D015986:Confounding Factors, Epidemiologic; D004164:Diphosphonates / Q000627:therapeutic use*; D050723:Fractures, Bone / Q000517:prevention & control*; D006620:Hip Fractures / Q000401:mortality; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid